FDA NDC Directory · JSON-LD · Markdown

clindamycin phosphate

NDC 0338-9545 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerBaxter Healthcare Company
Marketing categoryNew Drug Application (innovator) · App NDA208083
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsCLINDAMYCIN PHOSPHATE (300 mg/50mL)
Marketing started20170420
Package count1

External sources

Source: openFDA. Public-domain (CC0).